Device Trial Radar · NCT02149212
Iliac Vein Stenting in Advanced Chronic Venous Insufficiency
Last checked: Nov 20, 2026Latest source record: Jul 23, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Feb 2013
Primary completion
Jul 2014
Study completion Jul 2014
Sponsor
- Lead sponsor
- Instituto Dante Pazzanese de CardiologiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- First posted
- May 29, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
About 90 % of vascular symptoms affecting the lower limbs consist of venous diseases. Its highest incidence occurs from the second decade of life, affecting significantly the economically active population. Chronic Venous Insufficiency treatment aims to relieve symptoms, treat and prevent complications, prevent recurrences and provide cosmetic satisfaction with minimal side effects. It's current treatment includes some classic postural measures (leg elevation), elastic stockings and bandages compression therapy and possible medication (phlebotonics). The results in the medium and long term are unfavorable, since a large number of patients do not get better or evolves with recurrence of symptoms. Nowadays many, no prospective , not randomized , international studies have shown favorable results with endovascular treatment of obstruction in the iliac vein territory in patients with advanced Chronic Venous Insufficiency . The purpose of this prospective, double-blinded randomized study is to evaluate the results obtained with endovascular treatment, through the use of angioplasty and stenting in this group of patients when compared with clinical treatment .
Conditions
- Iliac Vein Obstruction
- May-Thurner Syndrome
- Cockett Syndrome
Interventions
PhlebotonicDrug
Aminaftone -- 75 mg BID
StentDevice
Iliac Vein Stenting
Limb elastic compression supportProcedure
CEAP 3-5 \> 20-30 mmHg compression stockings CEAP 6 \> elastic bandages
Unna boot dressingProcedure
CEAP 6 \> Unna boot dressing
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in pain on the Pain Visual Analogue Sacale at 6 monthsTime frame: 6 months
- Venous ulcer cicatrization at 6 monthsTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Instituto Dante Pazzanese de Cardilogia
São Paulo, São Paulo, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.